Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms
about
TWIST1 and BMI1 in Cancer Metastasis and ChemoresistanceNovel Molecular Markers for Breast CancerEpithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compoundsWAVE2 regulates epithelial morphology and cadherin isoform switching through regulation of Twist and AblThe proto-oncogene TWIST1 is regulated by microRNAsTwist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells.EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells.The role of TWIST, SERPINB5, and SERPIN1 genes in uterine leiomyomas.Twist1- and Twist2-haploinsufficiency results in reduced bone formation.Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway.A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells.High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.Expression levels of TWIST1 are associated with the clinicopathological stage of B-cell non-Hodgkin lymphoma.Genome-wide Twist1 occupancy in endocardial cushion cells, embryonic limb buds, and peripheral nerve sheath tumor cells.Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases.Twist1 controls a cell-specification switch governing cell fate decisions within the cardiac neural crestStructure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cellsThe expression of twist in differentiated thyroid carcinomas.Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.Endothelial TWIST1 promotes pathological ocular angiogenesis.Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells.DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer CellsThe Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein DegradationBasic helix-loop-helix transcription factor Twist1 inhibits transactivator function of master chondrogenic regulator Sox9.Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer CellsStimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.Regulation of the protein stability of EMT transcription factorsJak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate CancerA20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expressionCombination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis.Wt1 and β-catenin cooperatively regulate diaphragm development in the mouse.Twist-related protein 1-mediated regulation of mesenchymal change contributes to the migration and invasion of cervical cancer cellsDLX4 upregulates TWIST and enhances tumor migration, invasion and metastasisTWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemiaTwist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer
P2860
Q26744196-F14FD040-9F40-4273-A808-1A8D355E2061Q26753160-24799030-D070-4407-B186-2264DE3178CFQ27013565-3D5C43D7-6DAB-4E13-83EA-814924B31694Q27318554-B7FFCEF3-53A0-498E-8F03-9C094FF574EBQ28533475-29C5CFAA-F694-4425-A827-133E9DB0F740Q31143315-9AC88F36-4CF6-4786-A77D-026344283C07Q33798970-455BA73F-3352-4C67-824C-6D146D46880DQ33804808-EA9CE74D-779C-424C-9E1B-0884B53F0900Q33811879-82E8A679-1CC3-4CC8-8C06-480997D0EC18Q33817077-DBB1F5EF-78CD-483D-9DDD-0463DE861D1DQ33823252-CCCA79FA-A2F7-4AB1-8DA9-0D59C34DDC20Q33826227-17F959D1-C9FA-4997-98DA-E8FEC35E8782Q33898629-BE6C0335-CFF2-436D-B088-268DC4D89192Q33924237-7068BC3F-2893-4B80-8CFB-671C5C57708BQ34292362-5B144B7F-B0E6-4594-9EBF-0A5CFC770FC2Q34308984-7EE6360B-963B-471C-B514-F5BDE95AC304Q34412714-4949C188-3BE2-4638-A4C6-658A0675794BQ34650000-B6D9ABF7-2A17-47C0-A0F1-9B2DF0698233Q35024079-673164BF-9C32-415A-AC20-2EE5C2503D0AQ35121406-8D46E95A-7EF9-4586-B54E-D9DF5F0C71F1Q35131817-42CC4B95-E824-480C-B64B-988C2914030DQ35238430-3A19F67E-0C91-496D-A05C-A0F1315DE97CQ35441276-D534C664-6FDD-4473-8CE8-B5C3BDE39933Q35451620-5D01DB1A-0179-40B3-B292-08D03EBD3394Q35740131-2DAF3173-98CC-4565-BA77-9CE09CC75FC1Q35857237-75684B7C-DCEB-4ADE-AB77-7AB9F548C5C4Q35875807-0F6BA6B6-8525-4770-9E21-91A4F375C51EQ35956614-E01601C9-4650-45DA-9E0A-8761F8E4B652Q36033199-8F436CAF-AE73-4CED-929E-6C329A535E50Q36039878-A635F63A-3E15-4355-8D5C-47B4C04A66E9Q36119874-B1E02B50-F49B-4215-A93B-3D449D3EC3E4Q36124788-9EF2E3C5-503D-4F26-A2DD-2B1434B1A37EQ36134471-2F4FB5D6-E758-4FE9-9E11-BAB1775D2317Q36251372-68B3C3AD-CEAA-4B44-A908-7FF3B2833301Q36256977-C2709FF5-7CC1-4A59-9951-250DD3FD45B3Q36271500-1D7931F1-2A4F-4F00-8D29-CAA46496505EQ36336372-4E352FFF-0167-46A2-AF91-1CA52902EF44Q36337130-396A0659-09A3-492A-8B76-9AADEC036F6FQ36356216-E02E328B-EF15-43EF-AB9D-31B25740F9F4Q36545047-B4DCE8EA-4FA3-469E-BE3C-F4A61BD781FD
P2860
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Normal and disease-related bio ...... nderlying molecular mechanisms
@ast
Normal and disease-related bio ...... nderlying molecular mechanisms
@en
Normal and disease-related bio ...... nderlying molecular mechanisms
@nl
type
label
Normal and disease-related bio ...... nderlying molecular mechanisms
@ast
Normal and disease-related bio ...... nderlying molecular mechanisms
@en
Normal and disease-related bio ...... nderlying molecular mechanisms
@nl
prefLabel
Normal and disease-related bio ...... nderlying molecular mechanisms
@ast
Normal and disease-related bio ...... nderlying molecular mechanisms
@en
Normal and disease-related bio ...... nderlying molecular mechanisms
@nl
P2093
P2860
P3181
P356
P1433
P1476
Normal and disease-related bio ...... nderlying molecular mechanisms
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/CR.2011.144
P407
P577
2012-01-01T00:00:00Z
P5875
P6179
1020501796